Sotera Health(SHC)
Search documents
Sotera Health Announces Second-Quarter 2024 Earnings Release Date
Newsfilter· 2024-07-22 21:00
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company's website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health. Contacts Source: Sotera Health Company To participate in the live call, please dial 1-844-481-2916 if dialing-in from the United States, or 1-412-317- 0709 if dialing-in from other locations. A live webcast of the confe ...
Sotera Health Announces Second-Quarter 2024 Earnings Release Date
GlobeNewswire News Room· 2024-07-22 21:00
To participate in the live call, please dial 1-844-481-2916 if dialing-in from the United States, or 1-412-317- 0709 if dialing-in from other locations. A live webcast of the conference call can be accessed at this link or via the Investor Relations section of the Company's website at Presentation & Events | Sotera Health, along with the accompanying materials. A replay of the webcast will be available later in the day on August 5th. Jason Peterson Vice President & Treasurer, Sotera Health IR@soterahealth.c ...
Sotera Health Announces Closing of $1.5 Billion Term Loan B and $750 Million Senior Secured Note Financings
Newsfilter· 2024-05-30 21:12
CLEVELAND, May 30, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company ("Sotera Health" or the "Company") (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced that its direct subsidiary has successfully closed a new senior secured Term Loan B facility in an aggregate principal amount of $1.51 billion (the "TLB") as well as an issuance of senior secured notes in an aggregate principal amou ...
Sotera Health Announces Closing of $1.5 Billion Term Loan B and $750 Million Senior Secured Note Financings
GlobeNewswire News Room· 2024-05-30 21:12
CLEVELAND, May 30, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company ("Sotera Health" or the "Company") (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced that its direct subsidiary has successfully closed a new senior secured Term Loan B facility in an aggregate principal amount of $1.51 billion (the "TLB") as well as an issuance of senior secured notes in an aggregate principal amou ...
Sotera Health(SHC) - 2024 Q1 - Earnings Call Transcript
2024-05-03 14:32
Sotera Health Company (NASDAQ:SHC) Q1 2024 Earnings Conference Call May 2, 2024 9:00 AM ET Company Participants Jason Peterson - VP and Treasurer Michael B. Petras - Chairman and CEO Jonathan M. Lyons - SVP and CFO Conference Call Participants Patrick Donnelly - Citigroup Inc. Sean Dodge - RBC Capital Markets Casey Woodring - J.P. Morgan Chase Unidentified Analyst - Barclays Brett Fishbin - KeyBanc Capital Markets Michael Polark - Wolfe Research Operator Good morning, and welcome to the Sotera Health First ...
Sotera Health(SHC) - 2024 Q1 - Earnings Call Presentation
2024-05-03 11:33
3 Comprehensive end-to-end services offered (1) Based on revenue for the year ended December 31, 2023. • Nordion supplies high-specific activity (HSA) Cobalt-60 to use in Gamma Knife® radiosurgery for the precision treatment of brain cancer Adjusted EPS(1) $0.00 to $0.13 Business & Market Update Financial Performance • Top- and bottom-line growth compared to Q1 2023 • Completed annual customer satisfaction survey and received continued strong results • NESHAP regulations finalized in March 2024 7 2023 2024 ...
Sotera Health(SHC) - 2023 Q4 - Earnings Call Transcript
2024-03-03 05:15
Sotera Health Company (NASDAQ:SHC) Q4 2023 Earnings Conference Call February 27, 2024 9:00 AM ET Company Participants Jason Peterson - Vice President and Treasurer Michael Petras - Chairman and CEO Jon Lyons - Chief Financial Officer Conference Call Participants Sean Dodge - RBC Capital Dave Windley - Jefferies Luke Sergott - Barclays Brett Fishbin - KeyBanc Casey Woodring - JPMorgan Patrick Donnelly - Citi Michael Polark - Wolfe Research Operator Good morning and welcome to the Sotera Health Fourth Quarter ...
Sotera Health(SHC) - 2023 Q4 - Annual Report
2024-02-27 21:34
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-39729 SOTERA HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 47-3531161 (State or other jurisdiction of incorporation ...
Sotera Health(SHC) - 2023 Q3 - Earnings Call Transcript
2023-11-04 13:15
Sotera Health Company (NASDAQ:SHC) Q3 2023 Earnings Conference Call November 1, 2023 9:00 AM ET Corporate Participants Jason Peterson - Vice President and Treasurer Michael Petras - Chairman and Chief Executive Officer Jonathan Lyons - Senior Vice President and Chief Financial Officer Conference Call Participants Sean Dodge - RBC Capital Markets Patrick Donnelly - Citi Michael Polark - Wolfe Research Casey Woodring - JPMorgan Operator Good morning and welcome to the Sotera Health Third Quarter 2023 Conferen ...
Sotera Health(SHC) - 2023 Q3 - Quarterly Report
2023-11-01 20:53
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39729 SOTERA HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 47-3531161 (St ...